Stroke Diagnostic and Therapeutic Market Size, Share, and Trends 2025 to 2034

Stroke Diagnostic and Therapeutic Market Size and Forecast 2025 to 2034

The global stroke diagnostic and therapeutic market size was estimated at USD 38.98 billion in 2024 and is anticipated to reach around USD 83.91 billion by 2034, expanding at a CAGR of 7.96% from 2025 to 2034. The rising prevalence of ischemic stroke among geriatric population has boosted the growth of the stroke diagnostic and therapeutic market.

Stroke Diagnostic and Therapeutic Market Key Takeaways

• North America dominated the stroke diagnostic and therapeutic market with the largest market share of 26.64% in 2024.
• Asia Pacific is expected to expand at the fastest CAGR of 8.8% during the forecast period.
• By type, the diagnostics segment contributed the highest market share of 56.31% in 2024.
• By type, the therapeutics segment is projected to grow at a notable CAGR of 7.8%  during the forecast period.
• By application, the Ischemic stroke segment has held the biggest market share of 62.27% in 2024.
• By application, the hemorrhagic stroke segment is growing at a CAGR of 8.1%  during the forecast period

What is the Role of AI in the Stroke Management?

AI has been adopted in the overall healthcare sector for numerous applications ranging from drug manufacturing and diagnosing problems in the body. Recently, the stroke diagnosing and therapeutics companies have started integrating AI in their medical equipment for deriving accurate results to facilitate proper treatment. Also, AI-based diagnostic systems can help in detecting the nature of stroke along with providing insights about the patient’s health. Moreover, AI based software can be easily installed in diagnostic devices for early detection of strokes in human. Thus, the integration of AI in stroke diagnostic systems plays a vital role in shaping the industry in a positive direction.

• In October 2024, Royal Papworth launched an AI software. This AI-based software is designed for accurately diagnosing strokes in human beings.

U.S. Stroke Diagnostic and Therapeutic Market Size and Growth 2025 to 2034

The U.S. stroke diagnostic and therapeutic market size was evaluated at USD 5.88 billion in 2024 and is predicted to be worth around USD 12.64 billion by 2034, rising at a CAGR of 8% from 2025 to 2034.

North America is Valued to be the Major Market for Stroke Diagnostic And Therapeutic

North America dominated the stroke diagnostic and therapeutic market with the largest market share of 26.64% in 2024. The study report delivers prospects and trends of stroke diagnostic and therapeutic products across different geographical regions counting Europe, North America, Latin America, Asia-Pacific, Middle East, and Africa. However, geographically, the stroke diagnostic and therapeutic market is dominated by North America due to growing stroke patient’s pool in the countries U.S. and Canada, availability of advanced healthcare infrastructure, presence of key market players, and government initiatives that improve access to advanced power instruments the treatment of stroke in the North America.

Asia Pacific is expected to expand at the fastest rate during the forecast period. Increasing health awareness among the individuals in the emerging economies is expected to help in driving the growth of the global market in Asia Pacific region.

In Asia Pacific, the cases of haemorrhagic stroke has increased rapidly among the people of India, China, Japan and some others, that in turn increases the demand for advanced diagnostics machines, thereby boosting the market expansion. Also, the government of several countries are increasing their emphasis on stroke care and investing heavily for developing novel therapeutics for treating these diseases which in turn drives the market growth. Moreover, the technological advancement in medical devices sector coupled with research and development related to antihypertensive drugs for treating stroke is anticipated to foster the growth of the stroke diagnostic and therapeutic market.

Stroke Diagnostic and Therapeutic Market Growth Factors

• Increasing the number of patients at risk of developing stroke
• Increasing patient awareness
• Increased healthcare expenditure
• A large pool of the geriatric population

Key Market Insights

Growing ongoing research & development in the healthcare sector technologies for the stroke can create lucrative growth opportunities for the key players operating in the global market. In the developed countries such as U.S and Canada the healthcare treatment, service costs are relatively high owing to availability of advanced healthcare infrastructure. Due to the ongoing healthcare technology advancements highly sophisticated tools and apps are used every day, around the globe. Scientific and technical developments give rise to more powerful methods for disease prevention and recovery.

Despite various technical advancements benefiting different medical fields, it's no wonder that such innovations often create waves in stroke management. In addition to defining and recognizing the symptoms of this disease, both IT and mobile health apps provide valuable resources to resolve the issues that occur in this field. Technology also benefits healthcare providers, and without complex procedures, patients can monitor their heart health. Advanced technology also assists with prevention, diagnosis, and recovery. Further, growth in emerging economies is another factor to creating growth opportunity for the key players in the global market.

Future of Global Stroke Diagnostic and Therapeutic Market

Key companies like Medtronic plc and cerebrotech Medical Systems, Inc. are aiming towards profitable development by accepting strategies like mergers and acquisitions, weighty investments in the industrial facilities that is expectable to fuel the worldwide market growth in near future. This tendency is likely to continue and will enhance growth of the aiming industry in forecast time frame. In 2019, the leading player Boston Scientific Corporation introduced the Vercise Gevia Deep Brain Stimulation System as well as Vercise Primary Cell.

Market Scope

Segment Analysis

The Diagnostics Segment Is Predictable To Lead the Type Segment of Stroke Diagnostic and Therapeutic Market Revenue

On the basis of type the global market is segmented into two major types’ diagnostics and therapeutics types. he diagnostics segment contributed the highest market share of 56.31% in 2024. However, the therapeutics segment is projected to grow at a notable CAGR of 7.8%  during the forecast period.

Ischemic stroke Segment Is Likely to Take over the Application Segment of Stroke Diagnostic And Therapeutic Market Revenue

On the basis of application the global market is segregated into ischemic and hemorrhagic yes of stroke. The Ischemic stroke segment has held the biggest market share of 62.27% in 2024. Ischemic stroke is the most usual type of stroke which is caused by a blood clot that blocks a blood vessel in the brain. The hemorrhagic stroke segment is growing at a CAGR of 8.1%  during the forecast period.

Stroke Diagnostic and Therapeutic Market Companies

The companies focusing on research and development are expected to lead the global stroke diagnostic and therapeutic market. Foremost players contending in global stroke diagnostic and therapeutic market are as follows:

• Neural Analytics
• Cordis Corporation
• Cerebrotech Medical Systems, Inc.
• Koninklijke Philips N.V.
• Medtronic plc.
• Boston Scientific Corporation
• GE Healthcare
• Medfield Diagnostics
• Samsung Neurologica
• NIRX
• Gowerlabs
• Siemens AG
• Genentech Inc.
• Merck & Co., Inc.
• Hyperfine MRI
• Stryker Corporation
• Abbott Laboratories

Industry Leaders Announcements

In February 2024, Maria Sainz, the CEO of Hyperfine, Inc announced that the Swoop system will contribute significantly in the treatment and diagnosis of acute ischemic stroke.

Key Market Developments

• In December 2024, Canon Medical Systems USA launched an AI-enabled platform. This platform is designed for detecting stroke in human beings.
• In April 2024, CMUH launched a new stroke analysis platform in China. This platform is based on AI technology and helps in correctly analyzing the effect of acute ischemic stroke within 90 seconds.
• In February 2024, Philips launched Azurion neuro biplane. This image guided therapy system helps in detecting the damages caused by strokes.

Major Market Segments Covered:

By Type

• Diagnostics
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography Scan (CT scan)
  • Electrocardiography
  • Carotid Ultrasound
  • Cerebral Angiography
  • Others
• Therapeutics
  • Tissue Plasminogen Activator
  • Antiplatelet
  • Antihypertensive
  • Anticoagulant

By Application

• Haemorrhagic Stroke
• Ischemic Stroke

By Geography

• North America
  • • U.S.
    • Canada
• Europe
  • • Germany
    • France
    • United Kingdom
    • Rest of Europe
• Asia Pacific
  • • China
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
• Latin America
  • • Brazil
    • Rest of Latin America
• Middle East & Africa (MEA)
  • • GCC
    • North Africa
    • South Africa
    • Rest of Middle East & Africa